Do investors scrutinize CEOs more closely when they are women? It may not always be intentional, but research shows that subconscious bias does exist.
I have a vision for my company. I want us to be the market leader for non-viral drug delivery technology. We’ve already used synthetic biology to deliver therapeutic cargo into solid tumors. But I want our RNAi technology to target cells beyond solid tumors and deliver therapeutics to intracellular targets.
We raised our first investment within six months of setting up the company – and we are still raising investments today. This story ought to be nothing out of the ordinary – but there’s an unfortunate reality we must consider: Life sciences companies with female founders often have a harder time securing funding.